By Scientia Professor Matthew Colm Kiernan

Journal articles

Garg N; Park SB; Howells J; Noto YI; Vucic S; Yiannikas C; Tomlinson SE; Huynh W; Simon NG; Mathey EK; Spies J; Pollard JD; Krishnan AV; Kiernan MC, 2018, 'Anti-MAG neuropathy: Role of IgM antibodies, the paranodal junction and juxtaparanodal potassium channels', Clinical Neurophysiology, 129, pp. 2162 - 2169, http://dx.doi.org/10.1016/j.clinph.2018.07.021

Borire AA; Issar T; Kwai NC; Visser LH; Simon NG; Poynten AM; Kiernan MC; Krishnan AV, 2018, 'Correlation between markers of peripheral nerve function and structure in type 1 diabetes', Diabetes/Metabolism Research and Reviews, 34, http://dx.doi.org/10.1002/dmrr.3028

Tsugawa J; Dharmadasa T; Ma Y; Huynh W; Vucic S; Kiernan MC, 2018, 'Fasciculation intensity and disease progression in amyotrophic lateral sclerosis', Clinical Neurophysiology, 129, pp. 2149 - 2154, http://dx.doi.org/10.1016/j.clinph.2018.07.015

Ahmed RM; Dupuis L; Kiernan MC, 2018, 'Paradox of amyotrophic lateral sclerosis and energy metabolism', Journal of Neurology, Neurosurgery and Psychiatry, 89, pp. 1013 - 1014, http://dx.doi.org/10.1136/jnnp-2018-318428

Menon P; Kiernan MC; Vucic S, 2018, 'Cortical excitability varies across different muscles', Journal of Neurophysiology, 120, pp. 1397 - 1403, http://dx.doi.org/10.1152/jn.00148.2018

Makker PGS; Matamala JM; Park SB; Lees JG; Kiernan MC; Burke D; Moalem-Taylor G; Howells J, 2018, 'A unified model of the excitability of mouse sensory and motor axons', Journal of the Peripheral Nervous System, 23, pp. 159 - 173, http://dx.doi.org/10.1111/jns.12278

Agarwal S; Highton-Williamson E; Caga J; Matamala JM; Dharmadasa T; Howells J; Zoing MC; Shibuya K; Geevasinga N; Vucic S; Hodges JR; Ahmed RM; Kiernan MC, 2018, 'Primary lateral sclerosis and the amyotrophic lateral sclerosis–frontotemporal dementia spectrum', Journal of Neurology, 265, pp. 1819 - 1828, http://dx.doi.org/10.1007/s00415-018-8917-5

Baker MR; Dharmadasa T; Jaiser SR; Kiernan MC, 2018, 'Amyotrophic lateral sclerosis – Time for beta testing?', Clinical Neurophysiology, 129, pp. 1455 - 1456, http://dx.doi.org/10.1016/j.clinph.2018.04.613

Sheean RK; McKay FC; Cretney E; Bye CR; Perera ND; Tomas D; Weston RA; Scheller KJ; Djouma E; Menon P; Schibeci SD; Marmash N; Yerbury JJ; Nutt SL; Booth DR; Stewart GJ; Kiernan MC; Vucic S; Turner BJ, 2018, 'Association of regulatory T-Cell Expansion with progression of amyotrophic lateral sclerosis a study of humans and a transgenic mouse model', JAMA Neurology, 75, pp. 681 - 689, http://dx.doi.org/10.1001/jamaneurol.2018.0035

Dharmadasa T; Simon NG; Wang C; Vucic S; Kiernan MC, 2018, 'CLINICAL IMPLICATIONS OF CORTICAL DYSFUNCTION IN MOTOR NEURON DISEASE: A COMBINED STRUCTURAL AND FUNCTIONAL APPROACH', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 89, pp. E9 - E10, http://dx.doi.org/10.1136/jnnp-2018-ANZAN.21

Turner MR; Eisen A; Kiernan MC; Ravits J; Swash M, 2018, 'Kinnier Wilson's puzzling features of amyotrophic lateral sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 89, pp. 657 - 666, http://dx.doi.org/10.1136/jnnp-2017-317217

Garg N; Park SB; Howells J; Yiannikas C; Vucic S; Noto Y-I; Krishnan AV; Spies J; Mathey EK; Pollard JD; Kiernan MC, 2018, 'MECHANISMS OF NERVE DYSFUNCTION IN INFLAMMATORY NEUROPATHIES', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 89, pp. E3 - E3, http://dx.doi.org/10.1136/jnnp-2018-ANZAN.4

Nathani D; Barnett MH; Spies J; Pollard J; Kiernan MC, 2018, 'PREDICTING A DIAGNOSIS OF PATHOLOGICALLY CONFIRMED VASCULITIC NEUROPATHY', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 89, pp. E7 - E7, http://dx.doi.org/10.1136/jnnp-2018-ANZAN.15

Edwards LS; Barnett MH; Kieman MC, 2018, 'RITUXIMAB AND MAINTENANCE MYCOPHENOLATE MOFETIL FOR TREATMENT OF REFRACTORY ANTI-N-METHYL-D-ASPARTATE-RECEPTOR (NMDAR) ENCEPHALITIS', JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 89, pp. E44 - E45, http://dx.doi.org/10.1136/jnnp-2018-ANZAN.112

van Hummel A; Chan G; van der Hoven J; Morsch M; Ippati S; Suh L; Bi M; Asih PR; Lee WS; Butler TA; Przybyla M; Halliday GM; Piguet O; Kiernan MC; Chung RS; Ittner LM; Ke YD, 2018, 'Selective Spatiotemporal Vulnerability of Central Nervous System Neurons to Pathologic TAR DNA-Binding Protein 43 in Aged Transgenic Mice', American Journal of Pathology, 188, pp. 1447 - 1456, http://dx.doi.org/10.1016/j.ajpath.2018.03.002

Kandula T; Farrar MA; Cohn R; Mizrahi D; Carey K; Johnston K; Kiernan M; Krishnan A; Park SB, 2018, 'Chemotherapy induced peripheral neuropathy in long-term survivors of childhood cancer: neurophysiological, functional and patient reported outcomes.', JAMA Neurology, 75, pp. 980 - 988, http://dx.doi.org/10.1001/jamaneurol.2018.0963

Dharmadasa T; Huynh W; Tsugawa J; Shimatani Y; Ma Y; Kiernan MC, 2018, 'Implications of structural and functional brain changes in amyotrophic lateral sclerosis', Expert Review of Neurotherapeutics, 18, pp. 407 - 419, http://dx.doi.org/10.1080/14737175.2018.1464912

Noto YI; Simon NG; Selby A; Garg N; Shibuya K; Shahrizaila N; Huynh W; Matamala JM; Dharmadasa T; Park SB; Vucic S; Kiernan MC, 2018, 'Ectopic impulse generation in peripheral nerve hyperexcitability syndromes and amyotrophic lateral sclerosis', Clinical Neurophysiology, 129, pp. 974 - 980, http://dx.doi.org/10.1016/j.clinph.2018.01.061

Matamala JM; Howells J; Dharmadasa T; Trinh T; Ma Y; Lera L; Vucic S; Burke D; Kiernan MC, 2018, 'Inter-session reliability of short-interval intracortical inhibition measured by threshold tracking TMS', Neuroscience Letters, 674, pp. 18 - 23, http://dx.doi.org/10.1016/j.neulet.2018.02.065

Garg N; Park SB; Yiannikas C; Vucic S; Howells J; Noto YI; Mathey EK; Pollard JD; Kiernan MC, 2018, 'Neurofascin-155 IGG4 Neuropathy: Pathophysiological Insights, Spectrum of Clinical Severity and Response To treatment', Muscle and Nerve, 57, pp. 848 - 851, http://dx.doi.org/10.1002/mus.26010

Ahmed RM; Ke YD; Vucic S; Ittner LM; Seeley W; Hodges JR; Piguet O; Halliday G; Kiernan MC, 2018, 'Physiological changes in neurodegeneration-mechanistic insights and clinical utility', Nature Reviews Neurology, 14, pp. 259 - 271, http://dx.doi.org/10.1038/nrneurol.2018.23

Dharmadasa T; Kiernan MC, 2018, 'Riluzole, disease stage and survival in ALS', The Lancet Neurology, 17, pp. 385 - 386, http://dx.doi.org/10.1016/S1474-4422(18)30091-7

Issar T; Arnold R; Kwai NCG; Pussell BA; Endre ZH; Poynten AM; Kiernan MC; Krishnan AV, 2018, 'The utility of the Total Neuropathy Score as an instrument to assess neuropathy severity in chronic kidney disease: A validation study', Clinical Neurophysiology, 129, pp. 889 - 894, http://dx.doi.org/10.1016/j.clinph.2018.02.120

Van den Bos MAJ; Menon P; Howells J; Geevasinga N; Kiernan MC; Vucic S, 2018, 'Physiological processes underlying short interval intracortical facilitation in the human motor cortex', Frontiers in Neuroscience, 12, http://dx.doi.org/10.3389/fnins.2018.00240

Kandula T; Farrar MA; Krishnan AV; Murray J; Timmins HC; Goldstein D; Lin CSY; Kiernan MC; Park SB, 2018, 'Multimodal quantitative examination of nerve function in colorectal cancer patients prior to chemotherapy', Muscle and Nerve, 57, pp. 615 - 621, http://dx.doi.org/10.1002/mus.25968

Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Gotz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM, 2018, 'Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies (vol 141, pg 521, 2018)', BRAIN, 141, http://dx.doi.org/10.1093/brain/awy012

Nicolas A; Kenna KP; Renton AE; Ticozzi N; Faghri F; Chia R; Dominov JA; Kenna BJ; Nalls MA; Keagle P; Rivera AM; van Rheenen W; Murphy NA; van Vugt JJFA; Geiger JT; Van der Spek RA; Pliner HA; Shankaracharya ; Smith BN; Marangi G; Topp SD; Abramzon Y; Gkazi AS; Eicher JD; Kenna A; Logullo FO; Simone IL; Logroscino G; Salvi F; Bartolomei I; Borghero G; Murru MR; Costantino E; Pani C; Puddu R; Caredda C; Piras V; Tranquilli S; Cuccu S; Corongiu D; Melis M; Milia A; Marrosu F; Marrosu MG; Floris G; Cannas A; Capasso M; Caponnetto C; Mancardi G; Origone P; Mandich P; Conforti FL; Cavallaro S; Mora G; Marinou K; Sideri R; Penco S; Mosca L; Lunetta C; Pinter GL; Corbo M; Riva N; Carrera P; Volanti P; Mandrioli J; Fini N; Fasano A; Tremolizzo L; Arosio A; Ferrarese C; Trojsi F; Tedeschi G; Monsurrò MR; Piccirillo G; Femiano C; Ticca A; Ortu E; La Bella V; Spataro R; Colletti T; Sabatelli M; Zollino M; Conte A; Luigetti M; Lattante S; Santarelli M; Petrucci A; Pugliatti M; Pirisi A; Parish LD; Occhineri P; Giannini F; Battistini S; Ricci C; Benigni M; Cau TB; Loi D; Calvo A; Moglia C; Brunetti M, 2018, 'Genome-wide Analyses Identify KIF5A as a Novel ALS Gene', Neuron, 97, pp. 1268 - 1283.e6, http://dx.doi.org/10.1016/j.neuron.2018.02.027

Howells J; Bostock H; Park SB; Kiernan MC; Burke D, 2018, 'Tracking small sensory nerve action potentials in human axonal excitability studies', Journal of Neuroscience Methods, 298, pp. 45 - 53, http://dx.doi.org/10.1016/j.jneumeth.2018.02.003

Park SB; Kiernan MC, 2018, 'Oxaliplatin and neuropathy: A role for sodium channels', Clinical Neurophysiology, 129, pp. 670 - 671, http://dx.doi.org/10.1016/j.clinph.2017.12.028

Bodea L-G; Evans HT; Van der Jeugd A; Ittner LM; Delerue F; Kril J; Halliday G; Hodges J; Kiernan MC; Gotz J, 2018, 'Accelerated aging exacerbates a pre-existing pathology in a tau transgenic mouse model (vol 16, 377, 2017)', AGING CELL, 17, http://dx.doi.org/10.1111/acel.12712

Borire AA; Arnold R; Pussell BA; Kwai NC; Visser LH; Simon NG; Kiernan MC; Krishnan AV, 2018, 'Effects of hemodialysis on intraneural blood flow in end-stage kidney disease', Muscle and Nerve, 57, pp. 287 - 293, http://dx.doi.org/10.1002/mus.25704

Kiernan MC, 2018, 'Motor neuron disease in 2017: Progress towards therapy in motor neuron disease', Nature Reviews Neurology, 14, pp. 65 - 66, http://dx.doi.org/10.1038/nrneurol.2017.186

Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM, 2018, 'Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies', Brain, 141, pp. 521 - 534, http://dx.doi.org/10.1093/brain/awx328

Caga J; Hsieh S; Highton-Williamson E; Zoing MC; Ramsey E; Devenney E; Ahmed RM; Kiernan MC, 2018, 'Apathy and its impact on patient outcome in amyotrophic lateral sclerosis', Journal of Neurology, 265, pp. 187 - 193, http://dx.doi.org/10.1007/s00415-017-8688-4

Radakovic R; Puthusseryppady V; Flanagan E; Kiernan MC; Mioshi E; Hornberger M, 2018, 'Frontostriatal grey matter atrophy in amyotrophic lateral sclerosis: A visual rating study', Dementia e Neuropsychologia, 12, pp. 388 - 393, http://dx.doi.org/10.1590/1980-57642018dn12-040008

Dharmadasa T; Matamala JM; Huynh W; Zoing MC; Kiernan MC, 2018, 'Motor neurone disease', Handbook of Clinical Neurology, 159, pp. 345 - 357, http://dx.doi.org/10.1016/B978-0-444-63916-5.00022-7

Burke D; Kiernan MC, 2018, 'Stimulus, response and excitability – What is new?', Clinical Neurophysiology, 129, pp. 333 - 334, http://dx.doi.org/10.1016/j.clinph.2017.10.011

Garg N; Park SB; Howells J; Noto Y-I; Yiannikas C; Krishnan AV; Spies J; Pollard JD; Vucic S; Bostock H; Kiernan MC, 2018, '1. Axonal function in inflammatory neuropathy: The importance of conduction block', Clinical Neurophysiology, 129, pp. e1 - e1, http://dx.doi.org/10.1016/j.clinph.2017.12.014

Dharmadasa T; Matamala JM; Howells J; Vucic S; Kiernan MC, 2018, '10. Phenotypic variability in motor neuron disease: Site of onset and patterns of disease spread', Clinical Neurophysiology, 129, pp. e4 - e5, http://dx.doi.org/10.1016/j.clinph.2017.12.023

Howells J; Makker PGS; Lees JG; Matamala JM; Park SB; Kiernan MC; Burke D; Moalem-Taylor G, 2018, '11. Studying human neurophysiology using the mouse tail!', Clinical Neurophysiology, 129, pp. e5 - e5, http://dx.doi.org/10.1016/j.clinph.2017.12.024

Nathani D; Barnett M; Pollard JD; Spies J; Wang M-X; Kiernan MC, 2018, '12. Clinical and neurophysiological predictors of vasculitic neuropathy diagnosed on nerve biopsy', Clinical Neurophysiology, 129, pp. e5 - e5, http://dx.doi.org/10.1016/j.clinph.2017.12.025

Howells J; Trinh T; Burke D; Kiernan MC, 2018, '13. Threshold-tracking TMS without an MEP', Clinical Neurophysiology, 129, pp. e6 - e6, http://dx.doi.org/10.1016/j.clinph.2017.12.026

Shimatani Y; Matamala JM; Howells J; Kiernan MC, 2018, '3. Characterization of persistent Na + current in human motor and sensory axons: Exploring the activity at different target levels', Clinical Neurophysiology, 129, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2017.12.016

Tsugawa J; Noto Y-I; Dharmadasa T; Garg N; Kiernan MC, 2018, '4. Median/ulnar nerve ultrasound cross-sectional area ratio in ALS', Clinical Neurophysiology, 129, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2017.12.017

Timmins HC; Li T; Grimison P; Murray JE; Cox KM; Horvath LG; Lewis CR; Goldstein D; Kiernan MC; Park SB, 2018, '5. Neurophysiological dysfunction in chemotherapy-treated patients: Comparison of different platinum analogues', Clinical Neurophysiology, 129, pp. e2 - e3, http://dx.doi.org/10.1016/j.clinph.2017.12.018

van den Bos MAJ; Menon P; Geevasinga N; Kiernan MC; Vucic S, 2018, '6. ALS disability is predicted by a shift in the balance between short latency facilitatory and inhibitory circuits', Clinical Neurophysiology, 129, pp. e3 - e3, http://dx.doi.org/10.1016/j.clinph.2017.12.019

Walker S; Narasimhan M; Matamala JM; Dharmadasa T; Kiernan MC; Huynh W, 2018, '7. Papillary thyroid cancer in a patient with Morvan’s syndrome', Clinical Neurophysiology, 129, pp. e3 - e4, http://dx.doi.org/10.1016/j.clinph.2017.12.020

Li T; Howells J; Lin CSY; Garg N; Kiernan MC; Park SB, 2018, '8. Predicting motor disorders from nerve excitability studies', Clinical Neurophysiology, 129, pp. e4 - e4, http://dx.doi.org/10.1016/j.clinph.2017.12.021

Agarwal S; Highton-Williamson E; Matamala JM; Caga J; Howells J; Vucic S; Ahmed RM; Kiernan MC, 2018, '9. Upper motor neuron dysfunction and neuropsychological profile in PLS: Another entrant on the ALS-FTD spectrum', Clinical Neurophysiology, 129, pp. e4 - e4, http://dx.doi.org/10.1016/j.clinph.2017.12.022

Matamala JM; Howells J; Dharmadasa T; Trinh T; Ma Y; Vucic S; Burke D; Kiernan M, 2018, 'F147. Absolute and relative reliability of short-interval intracortical inhibition measured by threshold tracking transcranial magnetic stimulation', Clinical Neurophysiology, 129, pp. e122 - e123, http://dx.doi.org/10.1016/j.clinph.2018.04.310

Back to profile page